tirzepatide period and Menstrual Changes: Clinical Evidence – PlexusDx Do GLP-1 weight loss drugs

Observational Studies: Useful for long-term diet patterns, but only show associations

J Clin Endocrinol Metab (2023) 108(4):9718

Future research should prioritize long-term safety studies, real-world effectiveness analyses, and investigations into predictors of treatment response

RESEARCH INSIGHT: Phase 3 data shows participants maintained or even gained muscle while losing significant fat

New Delhi [India], January 3 (ANI): The impending patent expiry of semaglutide drugs across India, emerging markets and select regulated markets such as Canada and Brazil is expected to unlock a revenue opportunity exceeding Rs 50 billion for generic drug manufacturers over the next 12-15 months, according to an industry update by Systematix Institutional Research